Antiparkinsonian activity of adenosine A2A antagonists in experimental models

Adv Neurol. 1999:80:121-3.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adenosine / analogs & derivatives
  • Adenosine / pharmacology
  • Antiparkinson Agents / therapeutic use*
  • Humans
  • Motor Activity / physiology
  • Parkinson Disease / drug therapy*
  • Phenethylamines / pharmacology
  • Purinergic P1 Receptor Antagonists*
  • Receptors, Purinergic P1 / drug effects
  • Receptors, Purinergic P1 / physiology
  • Xanthines / pharmacology

Substances

  • Antiparkinson Agents
  • Phenethylamines
  • Purinergic P1 Receptor Antagonists
  • Receptors, Purinergic P1
  • Xanthines
  • 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine
  • KF 17837
  • Adenosine